• Issue

    The Prostate: Volume 78, Issue 13

    951-1041
    September 15, 2018
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information - Editorial Board

  • Page: 951
  • First Published: 06 August 2018

ORIGINAL ARTICLES

Thrombotic characteristics of extracellular vesicles derived from prostate cancer cells

Hassan A. Al Saleh,  Sandor Haas-Neill,  Ali Al-Hashimi,  Anil Kapoor,  Bobby Shayegan,  Richard C. Austin,  Khalid Al-Nedawi, 
  • Pages: 953-961
  • First Published: 15 May 2018

Heritable methylation marks associated with breast and prostate cancer risk

Pierre-Antoine Dugué PhD,  James G. Dowty PhD,  Jihoon E. Joo PhD,  Ee M. Wong PhD,  Enes Makalic PhD,  Daniel F. Schmidt PhD,  Dallas R. English PhD,  John L. Hopper PhD,  John Pedersen MBBS, PhD,  Gianluca Severi PhD,  Robert J. MacInnis PhD,  Roger L. Milne PhD,  Graham G. Giles PhD,  Melissa C. Southey PhD, 
  • Pages: 962-969
  • First Published: 29 May 2018

Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis

Petra Popovics PhD,  Renzhi Cai PhD,  Wei Sha BSc,  Ferenc G. Rick MD, PhD,  Andrew V. Schally PhD, MDhc (Multi), DSchc, 
  • Pages: 970-980
  • First Published: 21 May 2018

The identification of a novel antibody for CD133 using human antibody phage display

Paige M. Glumac,  Colleen L. Forster,  Hong Zhou PhD,  Paari Murugan MD,  Shilpa Gupta MD,  Aaron M. LeBeau PhD, 
  • Pages: 981-991
  • First Published: 22 May 2018

Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate

Mark C. Markowski MD, PhD,  Gretchen K. Hubbard PhD,  Jessica L. Hicks MS,  Qizhi Zheng MD,  Alexia King BS,  David Esopi BS,  Apurv Rege MS,  Srinivasan Yegnasubramanian MD, PhD,  Charles J. Bieberich MD,  Angelo M. De Marzo MD, PhD, 
  • Pages: 992-1000
  • First Published: 30 May 2018

The association between local atherosclerosis of the prostatic artery and benign prostatic enlargement in humans: Putative mechanism of chronic ischemia for prostatic enlargement

Nobuhiro Haga MD,  Hidenori Akaihata MD,  Junya Hata MD,  Ken Aikawa MD,  Tomohiko Yanagida MD,  Kanako Matsuoka MD,  Tomoyuki Koguchi MD,  Seiji Hoshi MD,  Soichiro Ogawa MD,  Masao Kataoka MD,  Yuichi Sato MD,  Kei Ishibashi MD,  Osamu Suzuki MD,  Yuko Hashimoto MD,  Yoshiyuki Kojima MD, 
  • Pages: 1001-1012
  • First Published: 21 May 2018

Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model

Petra W. van Duijn PhD,  Rute B. Marques PhD,  Angelique C.J. Ziel-van der Made BSc,  Hanneke J.A.A. van Zoggel PhD,  Ashraf Aghai BSc,  Cor Berrevoets BSc,  Reno Debets PhD,  Guido Jenster PhD,  Jan Trapman PhD,  Wytske M. van Weerden PhD, 
  • Pages: 1013-1023
  • First Published: 29 May 2018

Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-up

Marvin E. Langston PhD, MPH,  Ratna Pakpahan MBBS, MHS,  Remington L. Nevin MD, DrPH,  Angelo M. De Marzo MD, PhD,  Debra J. Elliott BA,  Charlotte A. Gaydos DrPH, MPH,  William B. Isaacs PhD,  William G. Nelson MD, PhD,  Lori J. Sokoll PhD,  Jonathan M. Zenilman MD,  Elizabeth A. Platz ScD, MPH,  Siobhan Sutcliffe PhD, 
  • Pages: 1024-1034
  • First Published: 30 May 2018

Treatment selection for men with metastatic prostate cancer who progress on upfront chemo-hormonal therapy

Pedro Barata MD, MSc,  Hamid Emamekhoo MD,  Prateek Mendiratta MD,  Vadim Koshkin MD,  Allison Tyler,  Moshe Ornstein MD, MSc,  Brian I. Rini MD, FACP,  Timothy Gilligan MD, FACP,  Christos Kyriakopoulos MD,  Jorge A. Garcia MD, 
  • Pages: 1035-1041
  • First Published: 07 June 2018